Literature DB >> 21300123

Metabotropic glutamate receptor 5 modulates the nitric oxide-cGMP pathway in cerebellum in vivo through activation of AMPA receptors.

Jordi Boix1, Marta Llansola, Andrea Cabrera-Pastor, Vicente Felipo.   

Abstract

Metabotropic glutamate receptors (mGluRs) modulate important processes in cerebellum including long-term depression, which also requires formation of nitric oxide (NO) and cGMP. Some reports suggest that mGluRs could modulate the NO-cGMP pathway in cerebellum. However this modulation has not been studied in detail. The aim of this work was to assess by microdialysis in freely moving rats whether activation of mGluR5 modulates the NO-cGMP pathway in cerebellum in vivo and to analyze the underlying mechanisms. We show that mGluR5 activation increases extracellular glutamate, citrulline and cGMP in cerebellum. Blocking NMDA receptors with MK-801 does not prevent any of these effects, indicating that NMDA receptors activation is not required. However in the presence of MK-801 the effects are more transient, returning faster to basal levels. Blocking AMPA receptors prevents the increase in citrulline and cGMP induced by mGluR5 activation, but not the increase in glutamate. The release of glutamate is prevented by tetrodotoxin but not by fluoroacetate, indicating that glutamate is released from neurons and not from astrocytes. Activation of AMPA receptors increases citrulline and cGMP. These data indicate that activation of mGluR5 induces an increase of extracellular glutamate which activates AMPA receptors, leading to activation of nitric oxide synthase and increased NO, which activates guanylate cyclase, increasing cGMP. The response mediated by AMPA receptors desensitize rapidly. Activation of AMPA receptors also induces a mild depolarization, allowing activation of NMDA receptors which prolongs the duration of the effect initiated by activation of AMPA receptors. These data support that the three types of glutamate receptors: mGluR5, AMPA and NMDA cooperate in the modulation of the grade and duration of activation of the NO-cGMP pathway in cerebellum in vivo. This pathway would modulate cerebellar processes such as long-term depression.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21300123     DOI: 10.1016/j.neuint.2011.01.025

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  4 in total

1.  Lack of neuronal nitric oxide synthase results in attention deficit hyperactivity disorder-like behaviors in mice.

Authors:  Yudong Gao; Scott A Heldt
Journal:  Behav Neurosci       Date:  2015-02       Impact factor: 1.912

Review 2.  Chronic hyperammonemia, glutamatergic neurotransmission and neurological alterations.

Authors:  Marta Llansola; Carmina Montoliu; Omar Cauli; Vicente Hernández-Rabaza; Ana Agustí; Andrea Cabrera-Pastor; Carla Giménez-Garzó; Alba González-Usano; Vicente Felipo
Journal:  Metab Brain Dis       Date:  2012-09-26       Impact factor: 3.584

3.  Evidence for involvement of nitric oxide and GABA(B) receptors in MK-801- stimulated release of glutamate in rat prefrontal cortex.

Authors:  Nicole L Roenker; Gary A Gudelsky; Rebecca Ahlbrand; Paul S Horn; Neil M Richtand
Journal:  Neuropharmacology       Date:  2012-05-09       Impact factor: 5.250

4.  Extracellular Cyclic GMP Modulates Membrane Expression of The GluA1 and GluA2 Subunits of AMPA Receptor in Cerebellum: Molecular Mechanisms Involved.

Authors:  Andrea Cabrera-Pastor; Lucas Taoro-González; Amparo N Cuñat; David Canet-López; Tiziano Balzano; Vicente Felipo
Journal:  Sci Rep       Date:  2017-12-15       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.